These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31762813)

  • 1. Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway.
    Liang Y; Zhu D; Zhu L; Hou Y; Hou L; Huang X; Li L; Wang Y; Li L; Zou H; Wu T; Yao M; Wang J; Meng X
    J Cancer; 2019; 10(24):6037-6047. PubMed ID: 31762813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39.
    Liang Y; Zhu D; Hou L; Wang Y; Huang X; Zhou C; Zhu L; Wang Y; Li L; Gu Y; Luo M; Wang J; Meng X
    Br J Cancer; 2020 Mar; 122(5):705-714. PubMed ID: 31919406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.
    Liang Y; Hou L; Li L; Li L; Zhu L; Wang Y; Huang X; Hou Y; Zhu D; Zou H; Gu Y; Weng X; Wang Y; Li Y; Wu T; Yao M; Gross I; Gaiddon C; Luo M; Wang J; Meng X
    Oncogene; 2020 Jan; 39(2):469-485. PubMed ID: 31597953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma.
    Han J; Sun W; Liu R; Zhou Z; Zhang H; Chen X; Ba Y
    Front Oncol; 2020; 10():1495. PubMed ID: 33072545
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
    Zhou Y; He A; Zhang L; Yi G
    Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
    Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
    Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
    Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
    J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.
    Han Z; Zhang C; Wang Q; Li L; Wang M; Li X; Yang C
    Clin Med Insights Oncol; 2021; 15():11795549211012666. PubMed ID: 34017210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.
    Sun S; Hang T; Zhang B; Zhu L; Wu Y; Lv X; Huang Q; Yao H
    Am J Transl Res; 2019; 11(9):5338-5356. PubMed ID: 31632515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
    Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
    Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer.
    Xie XQ; Wang MJ; Li Y; Lei LP; Wang N; Lv ZY; Chen KL; Zhou B; Ping J; Zhou ZG; Sun XF
    Mol Ther Oncolytics; 2020 Jun; 17():320-331. PubMed ID: 32382656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1.
    Ge T; Xiang P; Mao H; Tang S; Zhou J; Zhang Y
    Exp Ther Med; 2020 Sep; 20(3):2134-2140. PubMed ID: 32765688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.